Related Experiment Video
Updated: Jun 12, 2025

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
Published on: August 10, 2020
Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis
Hsiu-Jung Liao1,2, Hui-Ting Chen3,4,5, Chih-Hung Chang6,7
1Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei.
Abstract:
ObjectsOsteoarthritis (OA) is a widespread degenerative joint condition commonly occurring in older adults. Currently, no disease-modifying drugs are available, and safety concerns associated with commonly used traditional medications have been identified. In this review, a significant portion of research in this field is concentrated on cartilage, aiming to discover methods to halt cartilage breakdown or facilitate cartilage repair.MethodsResearchers have mainly investigated the cartilage, seeking methods to promote its repair. This review focuses on peptide-based molecules known for their ability to selectively bind to growth factor cytokines and components of the cartilage extracellular matrix.ResultsChondroinductive peptides, synthetically producible, boast superior reproducibility, stability, modifiability, and yield efficiency over natural biomaterials. This review outlines a chondroinductive peptide design, molecular mechanisms, and their application in cartilage tissue engineering and also compares their efficacy in chondrogenesis in vitro and in vivo.ConclusionsIn this paper, we will summarize the application of peptides engineered to regenerate cartilage by acting as scaffolds, functional molecules, or both and discuss additional possibilities for peptides. This review article provides an overview of our current understanding of chondroinductive peptides for treating OA-affected cartilage and explores the delivery systems used for regeneration. These advancements may hold promise for enhancing or even replacing current treatment methodologies.
Insights
Chondroinductive peptides offer a promising approach to cartilage repair for osteoarthritis. These synthetic molecules show superior properties over natural materials for cartilage regeneration, potentially improving OA treatments.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedics
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease in older adults.
- Current OA treatments lack disease-modifying drugs and face safety concerns.
- Research focuses on cartilage repair and halting degradation.
Purpose of the Study:
- To review chondroinductive peptides for cartilage regeneration in OA.
- To explore peptide design, mechanisms, and applications in tissue engineering.
- To compare in vitro and in vivo chondrogenesis efficacy.
Main Methods:
- Focus on peptide-based molecules targeting growth factors and cartilage matrix.
- Review of synthetic chondroinductive peptide design and molecular mechanisms.
- Analysis of peptide applications in cartilage tissue engineering.
Main Results:
- Chondroinductive peptides offer enhanced reproducibility, stability, and yield compared to natural biomaterials.
- Peptides can act as scaffolds, functional molecules, or both for cartilage regeneration.
- Efficacy of peptides in promoting chondrogenesis in vitro and in vivo is evaluated.
Conclusions:
- Chondroinductive peptides show potential for regenerating OA-affected cartilage.
- Delivery systems for peptide-based cartilage regeneration are discussed.
- These advancements may offer alternatives or improvements to current OA treatments.

